Immune reconstitution following stem cell transplantation

Area of Science:

• Immunology
• Hematology
• Oncology

Background:

• Immune deficiency post-stem cell transplantation (SCT) leads to high morbidity and mortality.
• Disease relapse is a major challenge, with immune system function critical for prevention.
• Early recovery of innate immunity contrasts with prolonged T and B lymphocyte dysfunction.

Purpose of the Study:

• To review recent advances in understanding immune reconstitution after allogeneic SCT.
• To highlight the importance of immune recovery for anti-tumor responses and novel therapies.
• To discuss factors influencing immune reconstitution, including graft type and graft-versus-host disease.

Main Methods:

• Review of recent immunological monitoring advances.
• Analysis of factors affecting T and B lymphocyte recovery post-SCT.
• Focus on allogeneic stem cell transplantation settings.

Main Results:

• Innate immunity recovers early, providing protection against bacterial pathogens.
• T and B lymphocyte levels and function remain impaired for extended periods.
• Specific T-cell subset recovery is being elucidated through advanced monitoring.

Conclusions:

• Immune reconstitution, particularly T and B cell recovery, is critical for long-term SCT success.
• Enhancing autologous anti-tumor responses and novel therapies depend on functional immune recovery.
• Further research into immune reconstitution post-SCT is vital for improving patient survival and reducing relapse rates.